Deep vein thrombosis
379 results
201 - 300
Compression therapy for prevention of post-thrombotic syndrome - Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
Obesity not associated with adverse hip replacement outcomes
Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE- Lower leg fractures
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Interventions for varicose veins and leg oedema in pregnancy
- Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
- Idarucizumab can reverse anticoagulation of dabigatran
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Sclerotherapy for varicose veins
- Injection sclerotherapy for varicose veins
- Tranexamic acid may reduce bleeding after cesarean delivery, but with a risk of adverse effects
- Topical application of tranexamic acid for the reduction of bleeding
- Vena caval filters for the prevention of pulmonary embolism
- Thromboprophylaxis for trauma patients: Cochrane systematic review
- Topical application of tranexamic acid for the reduction of bleeding: Cochrane systematic review
- Rutosides for treatment of post-thrombotic syndrome: Cochrane systematic review
- Vena caval filters for the prevention of pulmonary embolism
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
- Venous insufficiency of the lower limbs
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Leg oedema
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
- Simple risk score predicts severity of COPD exacerbations
- Simple risk model predicts risk of VTE after surgery
- Overweight in pregnancy
- Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
- Prolonged fever in the adult
- Antithrombotic agents in primary health care
- Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins: Cochrane systematic review
- Pulmonary embolism
- Treatment for femoral pseudoaneurysms: Cochrane systematic review
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Compression therapy for prevention of post‐thrombotic syndrome
- Prophylactic anticoagulants for non‐hospitalised people with COVID‐19
- ACCP 2016: updated guidelines for VTE
- Risk prediction model predicts VTE recurrence after initial thrombotic event
- Routine CT scans for occult malignancy not useful in patients with unprovoked VTE
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Antithrombotic treatment after stroke due to intracerebral haemorrhage
- Statins for the primary prevention of venous thromboembolism
- Tranexamic acid for reducing mortality in emergency and urgent surgery
- Total knee replacement more effective for pain and function than nonsurgical treatment
- Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization
- COVID-19 and other coronavirus infections
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Vascular closure devices for femoral arterial puncture site haemostasis
- Edoxaban as effective as LMWH for treatment of cancer-associated VTE
- SR: poor-quality data suggests stem cell joint injections are safe, but of unclear benefit
- Tinzaparin no better than warfarin in preventing recurrent VTE in adults with cancer
- Anticoagulants for people hospitalised with COVID‐19
- Preoperative education for hip or knee replacement: Cochrane systematic review
- Anticoagulants for acute ischaemic stroke
- Compression therapy for treating post‐thrombotic syndrome
- Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement: Cochrane systematic review
- Fixed-dose, subcutaneous, unfractionated heparin effective for VTE
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Statins for primary prevention of venous thromboembolism
- Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
- Standard‐ versus extended‐duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
- Peripherally inserted central catheter design and material for reducing catheter failure and complications
- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
- YEARS clinical decision tool decreases CT angiography in patients with suspected PE
- YEARS algorithm helpful for evaluating suspected PE in pregnant women
- Extended anticoagulation may be helpul for patients with unprovoked VTE or PE
- Femoral lines not associated with increased risk of bloodstream infections
- Edoxaban noninferior to warfarin for venous thromboembolism anticoagulation
- Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
- Postoperative tamoxifen for ductal carcinoma in situ
- Risk‐reducing medications for primary breast cancer: a network meta‐analysis
- Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
- Pulmonary embolism rule-out criteria reduces the need for CT pulmonary angiography in low-risk patients (PERC)
- Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer
- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Lenalidomide effective for relapsed multiple myeloma
- Small benefit to extended treatment with apixaban in selected patients with VTE
- Perioperative bridging anticoagulation unhelpful for invasive procedures
- Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults
- Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
- Adder (Vipera berus) bite
- Thromboprophylaxis with apixaban prevents VTE in high-risk cancer patients (AVERT); jury still out on rivaroxaban (CASSINI)
- Caesarean section versus vaginal delivery for preterm birth in singletons
- Anticoagulants versus non‐steroidal anti‐inflammatories or placebo for treatment of venous thromboembolism
- Self‐monitoring and self‐management of oral anticoagulation
- Warfarin initiation nomograms for venous thromboembolism: Cochrane systematic review
- Low-molecular-weight heparins vs. standard heparin for acute ischaemic stroke
- Apixaban slightly more effective and safe than warfarin, but more expensive